ValueQ4, 24Q1, 25Q2, 25Q3, 25TTMSelling/general/admin expenses196.64 M116.21 M113.69 M109.34 M535.88 MResearch & development26.03 M24.24 M23.13 M23.45 M96.85 MOperating income-23.86 M47.66 M54.46 M75.5 M153.75 MNon-Operating Income, Total1 M333 K-3.68 M-4.27 M-6.61 MInterest expense, net of interest capitalized2.18 M2.93 M2.17 M2.4 M9.69 MNon-Operating Income, excl. Interest Expenses2.36 M-2.6 M-5.85 M-6.67 M-12.76 MUnusual income/expense-3.54 M————Pretax income-22.86 M47.99 M50.78 M71.22 M147.14 MEquity in earnings1.11 M294 K110 K-739 K772 KTaxes-5.18 M9.81 M12.78 M20.18 M37.58 MNon-controlling/minority interest0————After tax other income/expense—————Net income before discontinued operations-17.68 M35.59 M38.01 M51.05 M106.96 MDiscontinued operations—2.6 M00—Net income-17.68 M38.19 M38.01 M51.05 M109.56 MDilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders-17.7 M38.18 M38 M51.04 M109.52 MBasic earnings per share (Basic EPS)-0.10.250.240.330.72Diluted earnings per share (Diluted EPS)-0.110.240.240.320.69Average basic shares outstanding157.52 M155.46 M155.84 M156.33 M—Diluted shares outstanding159.72 M156.36 M157 M157.4 M—EBITDA3.25 M72 M79.17 M99.66 M254.08 MEBIT-23.86 M47.66 M54.46 M75.5 M153.75 MCost of revenue118.15 M98.44 M104.6 M103.13 M424.32 MOther cost of goods sold—————Depreciation & amortization (cash flow)27.11 M24.34 M24.71 M24.17 M100.33 M
Bio-Techne Corp - Common Stock
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.